Nadroparin is an anticoagulant belonging to a class of drugs called low molecular weight heparins (LMWHs). Nadroparin is used in general and orthopedic surgery to prevent thromboembolic disorders (deep vein thrombosis and pulmonary embolism), and as treatment for deep vein thrombosis. It is also used to prevent clotting during hemodialysis, and for treatment of unstable angina and non-Q wave myocardial infarction.
This report contains market size and forecasts of Nadroparin Calcium in global, including the following market information:
Global Nadroparin Calcium Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nadroparin Calcium Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nadroparin Calcium companies in 2021 (%)
The global Nadroparin Calcium market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
3075AxaIU/0.3ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nadroparin Calcium include Boehringer Ingelheim, Abbott, Bayer Healthcare AG, GlaxoSmithKline Plc, Aspen Holdings, Pfizer, Inc, Eisai Inc, Teva Pharmaceutical Industries Ltd and Mitsubishi Tanabe Pharma Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nadroparin Calcium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nadroparin Calcium Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nadroparin Calcium Market Segment Percentages, by Type, 2021 (%)
3075AxaIU/0.3ml
4100AxaIU/0.4ml
6150AxaIU/0.6ml
Global Nadroparin Calcium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nadroparin Calcium Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Nadroparin Calcium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nadroparin Calcium Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nadroparin Calcium revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nadroparin Calcium revenues share in global market, 2021 (%)
Key companies Nadroparin Calcium sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nadroparin Calcium sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Abbott
Bayer Healthcare AG
GlaxoSmithKline Plc
Aspen Holdings
Pfizer, Inc
Eisai Inc
Teva Pharmaceutical Industries Ltd
Mitsubishi Tanabe Pharma Corporation
Sanofi S.A
Bristol-Myers Squibb Company
Dongcheng Biochemicals
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Tianjin Biochem Pharmaceutical
Changzhou Qianhong Bio-pharma